Related Experiment Video
Updated: Oct 27, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
How do I think about blood donor eligibility criteria for medical conditions?
1Medical Affairs and Innovation, Canadian Blood Services, Ottawa, Ontario, Canada.
Insights
Determining blood donor eligibility for medical conditions requires careful consideration of donor and recipient safety. This paper outlines Canada
Area of Science:
- Transfusion Medicine
- Hematology
- Public Health
Background:
- Blood donor eligibility criteria for medical conditions are often based on limited data and vary significantly.
- Establishing these criteria impacts donor safety, recipient safety, and blood product quality.
Purpose of the Study:
- To outline the potential impacts of donor medical conditions on safety and product quality.
- To describe a multidisciplinary approach to addressing donor eligibility criteria.
- To provide practical considerations for decision-making regarding donor eligibility.
Main Methods:
- Review of existing literature and practices.
- Description of a multidisciplinary expert panel approach.
- Distillation of years of experience into practical guidelines.
Main Results:
- Identified potential risks associated with donor medical conditions.
- Proposed a structured, collaborative approach to criteria development.
- Highlighted key factors for implementing changes in eligibility criteria.
Conclusions:
- A systematic, multidisciplinary approach is essential for developing robust blood donor eligibility criteria.
- Practical considerations and evidence-based data are crucial for ensuring blood supply safety and quality.
- This framework aims to assist medical and technical staff in making informed decisions on donor eligibility.
Abstract:
Every blood center must determine blood donor eligibility criteria for donors with medical conditions, often based on very limited published data and variable practice. This manuscript briefly outlines possible impacts of donor medical conditions on donor and recipient safety and product quality, and describes the multidisciplinary approach used in Canada to think about donor criteria issues. Many years of experience are distilled into practical considerations in determining criteria, possible sources of information, and factors for successful change implementation, to hopefully assist medical and technical staff engaged in decision-making around donor eligibility.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant I: Introduction
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...

